Ad­vent to sell stake in man­u­fac­tur­er and drug de­vel­op­er in a deal worth over $1B — re­port

Af­ter al­most three years of in­vest­ment, pri­vate eq­ui­ty firm Ad­vent In­ter­na­tion­al may look to sell its part in Bio­duro-Sun­dia.

A Reuters re­port on Mon­day de­tailed that Ad­vent In­ter­na­tion­al plans to sell a ma­jor­i­ty stake in the man­u­fac­tur­ing and drug de­vel­op­ment com­pa­ny that could val­ue the com­pa­ny at over $1 bil­lion, three peo­ple with knowl­edge of the mat­ter told the news site.

How­ev­er, one of the sources said that a for­mal sale might not hap­pen un­til next year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER